A randomized, double-blind, placebo-controlled add-on trial of quetiapine in patients with bipolar disorder and cocaine dependence.
Phase of Trial: Phase IV
Latest Information Update: 18 Nov 2015
At a glance
- Drugs Quetiapine (Primary)
- Indications Bipolar I disorders; Cocaine abuse
- Focus Therapeutic Use
- 17 Aug 2012 Actual end date (1 Dec 2007) added as reported by ClincalTrials.gov.
- 02 Aug 2011 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
- 02 Aug 2011 Planned end date (Dec 2007) added as reported by ClinicalTrials.gov.